Laetitia Fuhrmann
0000-0003-1755-6307
Institut Curie
3 papers found
Refreshing results…
EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
Missing publications? Search for publications with a matching author name.